期刊文献+

奥氮平与氯氮平治疗兴奋激越症状的成本-效果分析 被引量:2

下载PDF
导出
摘要 目的比较奥氮平与氯氮平治疗兴奋激越症状的成本.效果。方法有兴奋症状的精神患者60例分成两组,治疗组30例,奥氮平15~30mg·d^-1,对照组30例,氯氮平150—400mg·d^-1,观察2周,并以治疗前后简明精神病量表(BPRS)激越分减分率评定疗效,以不良反应量表评定安全性,作药物经济学评价。结果两组在1和2周末BPRS激越分均较疗前显著下降,治疗组2周有效率为76.7%,对照组有效率为72.4%。治疗组不良反应较对照组少。对照组成本明显低于治疗组。结论奥氮平与氯氮平治疗急性期兴奋激越患者疗效均肯定.但奥氡平威本比氢氡平高.
作者 尹海峰
出处 《医药导报》 CAS 2008年第10期1204-1206,共3页 Herald of Medicine
  • 相关文献

参考文献6

  • 1刘微波,李惠春,郑磊磊,禹华良,郭公宜.奥氮平与氯氮平对精神分裂症急性期的治疗研究[J].上海精神医学,2004,16(5):282-284. 被引量:11
  • 2王征,陈致宇,金雅君.奥氮平与氯氮平对照治疗兴奋激越症状的临床观察[J].中国新药杂志,2006,15(2):132-134. 被引量:4
  • 3张纪志,吉中孚.精神药物的合理应用[M].5版.北京:人民卫生出版社,2003:50-51.
  • 4WRIGHT P, BIRKETT M, MEEHAN K,et al. A double-blind study of intramuscular olanzapine, haloperidol and placebo in acutely agitated schizoprenic patients [ C ]. 22nd Collegium Internationale Neuro- Psychopharmacologicaum ,2000:9 - 13.
  • 5MELTZER H Y , FIBIGER H C . Olanzapine: a new atpical anti-psychotic drug[J].Neuropsychopharmacology, 1996,14 ( 2 ) : 83 - 85.
  • 6KARAGIANIS J L , DAWE I C ,THAKUR A ,et al . Rapid tranquilization with olanzapine in acute psychosis: a case series [ J]. J Clin Psychiatry ,2001,62 (Suppl 2) :12 - 16.

二级参考文献11

  • 1刘微波,李惠春,郑磊磊,禹华良,郭公宜.奥氮平与氯氮平对精神分裂症急性期的治疗研究[J].上海精神医学,2004,16(5):282-284. 被引量:11
  • 2Bilder RM, Goldman RS, Volavka J. Neurocognitive effects of clozapine, olazapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. American Journal of Psychiatry, 2002, 159(6) : 1018~28
  • 3Tollefson GD, Birkett MA, Kiesler GM, et al. Double-blind comparison of olazapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine. Biological psychiatry, 2001, 49(1) : 52~63
  • 4Littrell KH, Johnson CG, Hilligoss NM. Switching clozapine responders to olazapine. Journal of Clinical Psychiatry, 2000, 61(12) : 912-5
  • 5Meltzer HY, Fibiger HC. Olanzapine: a new atypical antipsychotic drug. Neuropsychopharmacology, 1996, 14 : 83-5
  • 6Tuunainen A, Wahlbeck K, Gilbody S. Newer atypical antipsychotic medication in comparison to clozapine. Schizophrenia Research, 2002, 56(1-2) : 1-10
  • 7Tollefson GD, Sanger TM. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol- controlled clinical trial with olanzapine. Am J Psychiatry, 1997, 154 : 466-74
  • 8张纪志 吉中孚.精神药物的合理应用[M](第5版)[M].北京:人民卫生出版社,2003.50-51.
  • 9WRIGHT P, BIRKETT M, MEEHAN K, et al, A double-blind study of intramuscular olanzapine, haloperidol and placebo in acutely agitated schizophrenic patients[C]//22nd Collegium Internationale Neuro-Psychopharmacologicaum. 2000:9 - 13.
  • 10MELTZER HY, FIBIGER HC. Olanzapine: a new atypical antipsychotic drug[J]. Neuropsychopharmacology, 1996,14 (2) :83 - 85.

共引文献13

同被引文献11

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部